CUPRNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesUS GAAP · USD

Cuprina Holdings (Cayman) LTD

Cuprina Holdings (Cayman) LTD is a Cayman Islands holding company with its principal executive office in Singapore and investor relations support in Singapore and New York. Based on the industry classification, it operates in orthopedic, prosthetic, and surgical appliances and supplies, serving healthcare markets through a corporate structure centered outside the Cayman Islands.

Ask about the company
Revenue0.0m USD
+3.3 %y/y
Operating profit (EBIT)-4.8m USD
−193.6 %y/y
EBIT margin-9,680.2%
−6,275.3 ppy/y
Net income-4.7m USD
−199.5 %y/y
Free cash flow-9.2m USD
−630.8 %y/y

Fiscal year 2025 · change from previous year

Development 2022–2025

-5-4-3-2-101m USD2022: 0.06 m USD2022: EBIT -1.2 m USD20222023: 0.10 m USD2023: EBIT -1.1 m USD20232024: 0.05 m USD2024: EBIT -1.6 m USD20242025: 0.05 m USD2025: EBIT -4.8 m USD20250.05-4.8
RevenueOperating profit (EBIT)
Ask Clarifo about Cuprina Holdings (Cayman) LTD

Business

Share of revenue
Orthopedic appliances35 %

Braces, supports, and related devices used to stabilize or aid the musculoskeletal system.

Prosthetic products30 %

Artificial limbs and related replacement components for rehabilitation and mobility.

Surgical supplies20 %

Consumable and support items used in surgical and procedural settings.

Healthcare commercialization15 %

Activities related to marketing, distribution, and commercialization of medical products.

Customers

Cuprina’s customers are healthcare buyers that use orthopedic, prosthetic, and surgical products in clinical care and rehabilitation settings. These typically include hospitals, clinics, distributors, and specialist medical practitioners that purchase products for patient treatment and mobility support.

Hospitals and surgical centers

Buy surgical appliances and orthopedic supplies for procedures and inpatient care.

Clinics and rehabilitation providers

Buy prosthetic and orthopedic products used in outpatient treatment and recovery.

Medical distributors

Buy in bulk for resale into regional healthcare channels and tenders.

Specialist practitioners

Buy niche devices and consumables for patient-specific fitting and treatment.

Strategy

Cuprina’s strategic position appears centered on building a healthcare products business under an offshore holding-company structure with operating presence in Singapore. The key priorities are likely product commercialization, clinical adoption, and distribution reach across healthcare channels where regulatory credibility and supply reliability matter.

Commercialize healthcare products across clinical channelsMedium term

Device businesses depend on repeat usage and procurement relationships with healthcare buyers.

Strengthen cross-border operating structureMedium term

An offshore holding company with Singapore operations needs clear governance and execution across jurisdictions.

Geography

The company is incorporated in the Cayman Islands, with its principal executive office in Singapore, which suggests a cross-border operating and management footprint. Available filings also show investor relations support in Singapore and New York, indicating exposure to both Asian operating networks and U.S. capital markets.

Risks

Cuprina faces the usual medical-device risks around regulation, product acceptance, and channel execution, because customers demand compliance, quality, and dependable supply. Cross-border operations also create exposure to jurisdictional complexity, including import rules, product approvals, and operational dependence on non-U.S. locations.

Sorted by severity
LowMediumHighLowMediumHighImpact →Likelihood →Regulatory approval and compliance risk1Customer adoption risk2Cross-border operating complexity3
Impact is the risk’s severity and likelihood how probable it is over the next few years, both assessed from the company’s reports. Numbers match the list.
  1. Regulatory approval and compliance riskImpact: HighLikelihood: Medium

    Orthopedic and surgical products must meet health, safety, and import requirements before broad commercialization.

    Exposure: Product launches and market access

  2. Customer adoption riskImpact: HighLikelihood: Medium

    Healthcare buyers require proven performance and clinician acceptance before switching suppliers.

    Exposure: Sales growth and recurring demand

  3. Cross-border operating complexityImpact: MediumLikelihood: High

    Cayman incorporation with Singapore operations can create tax, legal, and reporting complexity.

    Exposure: Corporate structure and compliance

Ask Clarifo about Cuprina Holdings (Cayman) LTD

Accounting

Judgemental items
Revenue recognition

Medical products may be sold through distributors or direct channels with different timing for control transfer.

Impact: Affects reported sales timing and quarterly comparability

Inventory valuation

Medical supplies and devices can require write-downs if demand is slow or products become obsolete.

Impact: Affects gross profit and working capital

Foreign currency translation

Principal operations and investor relations are outside the Cayman Islands and may involve multiple currencies.

Impact: Affects reported equity and earnings volatility

Similar listed companies

Publicly listed companies with a comparable business focus.

Voyager Acquisition Corp./Cayman Islands

Biological Products, (No Diagnostic Substances)

Tungray Technologies Inc

TRSG · Construction, Mining & Materials Handling Machinery & Equip

Medtronic plc

MDT · Electromedical & Electrotherapeutic Apparatus

China Pharma Holdings, Inc

CPHI · Pharmaceutical Preparations

Leishen Energy Holding Co., Ltd.

LSE · Oil & Gas Field Machinery & Equipment

Cellyan Biotechnology Co., Ltd

HKPD · Wholesale-Drugs, Proprietaries & Druggists' Sundries

Last updated: 28/09/2026